Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Kevin Rue-Albrecht, who has been selected as one of BioFAIR’s inaugural Pathfinder Projects.

Kevin Rue-Albrecht will lead a BioFair Pathfinder Project

BioFAIR is a joint Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) project, which is dedicated to advancing life science research by improving the Findability, Accessibility, Interoperability, and Reusability (FAIR) of research data. The BioFAIR Pathfinder Projects will act as exemplars, driving requirements for the BioFAIR initiative and developing proofs-of-concept that can benefit from, and be incorporated into, the national infrastructure.

Dr Kevin Rue-Albrecht, from the MRC WIMM Centre for Computational Biology, successfully applied for funding for his project “Connecting Bioconductor, Galaxy, and nf-core: FAIR, AI-ready workflows and training for single-cell analysis”.

Using single-cell data analysis as a focused scientific test case, this project aims to build stronger connections between three major bioinformatics platforms: Bioconductor, Galaxy and nf-core.

Although many powerful tools already exist, differences in packaging and metadata make them hard to find, combine and reuse across a fragmented research software landscape. The team will develop shared, well-documented example workflows, align metadata so tools can be discovered across platforms, and deliver hands-on training to help researchers apply them to their own data.

Beyond improving current practice, the project is designed as a model for how different software communities can work together around common FAIR standards. By demonstrating practical, cross-platform solutions, it aims to act as a springboard for wider collaboration and future FAIR-by-design infrastructure across the life sciences.

Similar stories

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.

New pump-priming awards support cross-cutting research across RDM

Five Radcliffe Department of Medicine research teams have secured pump-priming funding to support new collaborations and early-stage research aligned with RDM’s cross-cutting research themes.

First real-world trial shows AI could reduce need for contrast injections in heart MRI scans

The technology could make advanced heart MRI faster, cheaper and more accessible.

Beyond cancer dependency maps: the PRECISE vision

Dr Sumana Sharma is one of the founding partners of a major new pan-European initiative that aims to transform how scientists identify and target cancer's weaknesses, moving beyond simply mapping cancer vulnerabilities towards predicting them before they are experimentally tested.

MRC WIMM achieves Gold Green Impact award

Congratulations to the Institute's Green Impact team, who achieved Gold in the University of Oxford's 2026 Green Impact awards.

New personalised therapy targets chronic blood cancer

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.

Similar stories

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.

New pump-priming awards support cross-cutting research across RDM

Five Radcliffe Department of Medicine research teams have secured pump-priming funding to support new collaborations and early-stage research aligned with RDM’s cross-cutting research themes.

First real-world trial shows AI could reduce need for contrast injections in heart MRI scans

The technology could make advanced heart MRI faster, cheaper and more accessible.

Beyond cancer dependency maps: the PRECISE vision

Dr Sumana Sharma is one of the founding partners of a major new pan-European initiative that aims to transform how scientists identify and target cancer's weaknesses, moving beyond simply mapping cancer vulnerabilities towards predicting them before they are experimentally tested.

MRC WIMM achieves Gold Green Impact award

Congratulations to the Institute's Green Impact team, who achieved Gold in the University of Oxford's 2026 Green Impact awards.

New personalised therapy targets chronic blood cancer

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.